NANOCARRIER

We are pushing ahead with research into DDS for nucleic acid medicines using siRNA, ASO, and mRNA. Our aim is to promote unprecedented innovation in nucleic acid-based therapies for conditions such as breast cancer and glioblastoma and to make therapies that lessen the patient burden available quickly.

Also known as: NANO MRNA Co.,Ltd., NanoCarrier Co., Ltd.